Serum Endostatin Levels in Oral Squamous Cell Carcinoma

Mardani, Maryam and Andisheh-Tadbir, Azadeh and Ranjbar, Mohammad Ali and Khademi, Bijan and Fattahi, Mohammad Javad and Rahbar, Ahmad (2018) Serum Endostatin Levels in Oral Squamous Cell Carcinoma. Iranian Journal of Otorhinolaryngology, 30 (3). pp. 125-130.

[img] Text
IJORL_Volume 30_Issue 3_Pages 125-130.pdf

Download (377kB)
Official URL: http://ijorl.mums.ac.ir/article_10696.html

Abstract

Introduction: Endostatin is a C-­terminal proteolytic fragment of collagen XVIII and, as with angiostatin and thrombospondin, is known as an anti­angiogenic agent. The aim of this study was to assess the level of serum endostatin in patients with oral squamous cell carcinoma (SCC), and its association with the clinicopathological characteristics of the tumor. Materials and Methods: Using an enzyme-linked immunosorbent assay (ELISA) kit, we investigated the circulating levels of endostatin in the blood serum of 45 patients with oral SCC and 45 healthy controls. Results: The mean level of serum endostatin in patients was significantly lower (68.8±85 ng/ml) than in healthy controls (175.6±73 ng/ml) (P<0.001). Serum endostatin levels were significantly lower in patients with lymph node metastasis compared with patients without lymph node metastasis (P<0.001). In addition, serum endostatin level was associated with higher histological grade (P<0.001). There were no apparent correlations between serum endostatin concentration and clinicopathological features such as age, gender, and tumor stage (P>0.05). Conclusion: Findings of the present study suggest the prognostic and anti-metastatic role of endostatin, and this may be used as a tool for monitoring tumor progression.

Item Type: Article
Subjects: WV Otolaryngology
Divisions: Journals > Iranian J Otorhinolaryngology
Depositing User: ijo ijo
Date Deposited: 30 Sep 2018 06:51
Last Modified: 30 Sep 2018 06:51
URI: http://eprints.mums.ac.ir/id/eprint/10452

Actions (login required)

View Item View Item